Safety setbacks threaten New York's office-to-housing conversion push
Structural problems at several Manhattan office-to-apartment projects have triggered stop-work orders, raising doubts about the city’s key affordable-housing strategy.
Recent safety inspections have forced a halt to three high-profile office-to-residential conversions in Manhattan, including the former Pfizer building, 222 Broadway, and 750 Third Avenue, due to structural flaws in steel columns and a cracked concrete beam. These setbacks expose the engineering complexities of repurposing office spaces, which often lack the plumbing, window operability and sunlight access required for apartments.
Experts such as Emma Waters of the Bipartisan Policy Center note that retrofitting can be costly and project-specific, while developer David Schwartz points to the difficulty of cutting through existing concrete. Despite the setbacks, the city converted 5 million square feet of office space in 2024, up from 2.7 million the previous year, and continues to rely on conversions to meet Mayor Zohran Mamdani’s goal of 200,000 new homes.
The administration is reviewing safety documentation and streamlining permits, and federal housing grants aim to offset conversion costs. Nonetheless, rising rents and a persistent supply gap keep affordable housing a pressing concern.
Why it matters
Delays in office conversions could slow New York's effort to add affordable homes amid a severe housing shortage.
In this story
